GE Healthcare launched Discovery NM/CT 670
GE Healthcare announced the European launch of Discovery NM/CT 670, a hybrid imaging platform designed to improve workflow, dose management, and overall image quality.
Markets
GE Launches $250 Million Healthymagination Fund
GE announced today the formation of the GE Healthymagination Fund, a new equity fund that will make investments in highly promising healthcare technology companies. The fund will invest in companies globally that have innovative diagnostic, IT, and life sciences technologies aligned with the strategic objectives of GE´s Healthymagination initiative. The fund will also support healthcare…
Invatec launches Self-Expanding Peripheral Stent System
Invatec, a comprehensive innovator of interventional products, launched their latest self-expanding peripheral stent system, Maris Plus, at CIRSE 2009. The Maris Plus stent has a “lesion-specific” design with larger sizes to meet the clinical requirements of the iliac region.
Article • Picture Archiving and Communication System
The Carestream Cardiology PACS
From this October, a newly launched, web-based cardiology PACS will change the workload of cardiologists at Groene Hart Ziekenhuis, in The Netherlands, making the 500-bed hospital one of Europe's first to benefit from this valuable system that consolidates isolated cardiac lab systems into one centralised solution.
Synthetic lethality
Completion of a Phase I clinical trial has demonstrated the great promise of a completely new type of cancer treatment, according to results announced this June in The New England Journal of Medicine by scientists at the Institute of Cancer Research (ICR) and the Royal Marsden Hospital in the United Kingdom, working with pharma firm AstraZeneca.
J&J acquires Cougar
Positive CB7630 (Abiraterone Acetate) Phase II Data was presented at the ASCO Annual Meeting in Chicago this May/June, Cougar Biotechnology Inc, a development stage biopharmaceutical firm with a specific focus on oncology. In mid-July, Johnson & Johnson announced its acquisition of Cougar, which is now working with Ortho Biotech Oncology Research & Development, a division of the J&J firm Centocor…
France prepares for another H1N1 outbreak
Experts predict that 25-50% of the French population could be affected by the H1N1 flu this autumn. According to Patrick Berche, head of the microbiology department at the Necker Hospital in Paris, the likely second wave of the epidemic would produce a great number of cases due to the highly contagious nature of the virus.
Silenced genes as a warning sign of blood cancer
In the genetic material of cancer cells, important growth inhibitors are often switched off by chemical labels in the DNA. Scientists of the German Cancer Research Center and the Ohio State University, USA, discovered in mice that cancer-typical DNA labeling occurs long before the first symptoms of leukemia appear. A test for the genetic label might therefore help to detect a developing cancer at…
Wireless technology in healthcare: a multidimensional evolution
Healthcare in Europe is increasingly becoming digitised and there is growing need to develop and deploy sophisticated information systems. However, the wireless technology that is transforming various areas of business today is yet to be fully explored by the healthcare industry to support quality maintenance and improved efficiency.
Agendia expands laboratory capacity
Agendia announced the official opening of its new headquarters at Amsterdam's Science Park at Watergraafsmeer, Kruislaan 406. The Grand Opening ceremony was officiated by Dr. Rene Bernards, Chief Scientific Officer at Agendia and the Honourable Director General Mrs. R.M. Bergkamp, on behalf of the Honourable Mrs. Maria van der Hoeven, Minster of Economic Affairs for The Netherlands.
Speeding up vaccine production
During the race to produce vaccines against evolving influenza viruses the slowness of their manufacture has turned producers more sharply towards cell culture technology. Using the traditional process, fertilised chicken eggs must first be inoculated with live flu virus, then the resulting egg-adapted virus must be purified and inactivated to produce trivalent inactivated virus (TIV), during…
Simulation training in Europe
In many countries, simulation training is well-established as a core part of training for doctors and medical personnel.
The 15th Congress of SESAM (Society in Europe for Simulation Applied to Medicine)
Professor Wolfgang Heinrichs, of the AQAI Simulation Centre Mainz, Germany, notes that the 15th SESAM congress slogan "Europe-tradition and innovation in simulation", was born out by the choice of venue, the Mainz Simulation Centre was one of the first of its kind in Europe, and also hosted the 2000 SESAM congress.
Ziosoft and Medicor announce partnership agreement
Ziosoft, Inc. a leader in advanced visualization and analysis software for medical imaging and MMS Medicor Medical Supplies GmbH Kerpen (Medicor), a leading distributor of medical products in Europe, announced today that the companies have signed an exclusive agreement for Medicor to distribute Ziosoft's 3D thin-client software solutions in Germany, Austria and Switzerland.
Pulmonary hypertension: New drugs improve quality of life
Today help is often available for those suffering from high blood pressure in the pulmonary circulation (pulmonary arterial hypertension/PAH). New drugs — so-called endothelin receptor antagonists — make it possible to alleviate the symptoms, improving patients' physical strength and quality of life.
Laser microdissection technology
The new Leica LMD7000 is a laser microdissection system with a power-adjustable, high precision laser.
Robots yes, but let's keep the patient in full focus
Surgeons using technology-supported surgical systems, e.g. lasers and robotics, are challenged not to lose sight of the human element, which influenced the theme Humanity through technology for the 126th Annual Congress of the German Society for Surgery (DGCH) held in Munich this April.
Met at KIMES
During KIMES, Karoline Laarmann (European Hospital) met with Joong-Ho Lee, Senior Executive Vice President of the ultrasound systems manufacturer MEDISON, the Korean firm that entered the ultrasound market in the 1980s and quickly established a global reputation for innovative developments (e.g. the firm produced the first commercial real-time 3-D ultrasound scanner).
The switch from analogue to digital
Analogue screening systems are gradually being replaced by digital mammography systems, and breast cancer screening programmes are increasing sales. The majority of European countries have implemented in European countries, but in some others their introduction is slow, but steady. Additionally, Europe has significant geographic diversity, and remote places served by mobile screening units…
The Shenzhen Comen Medical Instruments Company
Founded in 2001, Shenzhen Comen Medical Instruments Co. Ltd. is one of the few Chinese firms to possess comprehensive core technologies for the manufacturing of monitors and medical diagnostic products.
The future is digital
At ECR healthcare manufacturers not only introduced the latest products, but also the future technologies and trends that will have an impact on the market in the coming years.
Ultrasound-MRI fusion imaging
Tissue removal is currently the only way to verify suspicious lesions in the prostate. It is also a key requirement before treating prostate carcinomas. The standard biopsy is performed with transrectal ultrasound (TRUS) to guide the needle in the right direction.
The 75th DGK Congress
In April, the 75th annual congress of the German Cardiac Society (DGK) was considered a great success, drawing in some 7,900 specialists.
The TopClinica Congress
24-26 June Stuttgart, Germany